Epigenomics

Discipline	Epigenomics
Language	English
Edited by	James G. Herman, Jörg Tost
Publication details
History	2009–present
Publisher	Future Medicine Ltd
Frequency	Monthly
Impact factor	4.778 (2020)
Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt )
ISO 4	Epigenomics
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus
CODEN	EPIGC7
ISSN	1750-1911 (print) 1750-192X (web)
OCLC no.	746948365
Links
Journal homepage

Epigenomics is a peer-reviewed medical journal established in 2009 and published by Future Medicine. The editors-in-chief are James G. Herman (University of Pittsburgh Cancer Institute) and Jörg Tost (Centre national de génotypage [fr]). The journal covers all aspects of research on epigenomics and epigenetics and their implications for diagnosis, prognosis and therapeutics.

The journal is abstracted and indexed in EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Chemical Abstracts, BIOSIS Previews, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2017 impact factor of 4.979, ranking it 31st out of 166 journals in the category "Genetics & Heredity".^[1]

• Official website